Medicare Enrolled
Dr. Naga Bushan, MD
Rheumatology · Lubbock, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bushan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bushan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bushan
Dr. Naga Bushan is a rheumatology specialist in Lubbock, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bushan performed 160,986 Medicare services across 4,455 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bushan received a total of $4,012 from 16 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bushan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in TX
$4,012 industry payments
Medicare Practice Summary
Medicare Utilization ↗160,986
Medicare services
Top 8% in TX for rheumatology
4,455
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,049 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 83,282 | $4 | $8 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
37,926 | $10 | $49 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
13,100 | $32 | $82 |
| Denosumab injection (Prolia/Xgeva) | 10,800 | $18 | $35 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,621 | $26 | $200 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
3,652 | $63 | $187 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
778 | $7 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
645 | $7 | $25 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
495 | $10 | $35 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
423 | $4 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
413 | $58 | $140 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
399 | $95 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $84 | $207 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
375 | $5 | $36 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
373 | $21 | $70 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
332 | $47 | $125 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
195 | $11 | $50 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
178 | $2 | $10 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
177 | $1 | $5 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
124 | $3 | $10 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
119 | $28 | $80 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
111 | $5 | $15 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
110 | $18 | $50 |
| Alkaline phosphatase level test A blood test that measures the level of alkaline phosphatase, an enzyme found in the liver and bones. |
89 | $5 | $15 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
89 | $5 | $15 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
89 | $5 | $15 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
80 | $34 | $200 |
| Rheumatoid factor level | 69 | $5 | $20 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
67 | $8 | $30 |
| Liver function blood test panel | 59 | $8 | $25 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
58 | $12 | $35 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
55 | $6 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $109 | $318 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
50 | $12 | $75 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
48 | $21 | $50 |
| Acute hepatitis panel A blood test that screens for markers of acute viral hepatitis infection. |
42 | $47 | $140 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
35 | $20 | $50 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
29 | $13 | $40 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
24 | $5 | $15 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
22 | $33 | $100 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
17 | $47 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.6% high complexity
61.3% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,012
Total received (2018-2024)
Avg $573/year across 7 years
Bottom 48% in TX for rheumatology
16
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,012 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$733
2023
$533
2022
$370
2021
$457
2020
$393
2019
$876
2018
$650
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$839
AbbVie Inc.
$691
ABBVIE INC.
$562
GlaxoSmithKline, LLC.
$346
Novartis Pharmaceuticals Corporation
$320
PFIZER INC.
$313
AbbVie, Inc.
$270
Janssen Biotech, Inc.
$183
Genentech USA, Inc.
$135
Otsuka America Pharmaceutical, Inc.
$94
DePuy Synthes Sales Inc.
$87
Horizon Therapeutics plc
$64
Horizon Pharma plc
$46
Lilly USA, LLC
$24
E.R. Squibb & Sons, L.L.C.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$16
Top 3 companies account for 52.1% of total payments
Associated products mentioned in payments ›
Actemra · BENLYSTA · COSENTYX · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · INFLECTRA · JYNARQUE · KRYSTEXXA · MONOVISC · ORENCIA · PENNSAID · Prolia · REMICADE · RINVOQ · Rinvoq · Rituxan · SIMPONI · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · Tavneos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
4
Per 100K population
1.3
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bushan is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bushan experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Bushan performed 83,282 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bushan receive payments from pharmaceutical companies?
Yes. Dr. Bushan received a total of $4,012 from 16 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bushan's costs compare to other rheumatologists in Lubbock?
Dr. Bushan's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bushan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Lubbock
Browse rheumatologists in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology